GPRC5A and non-small cell lung carcinoma: ATRA treatment induced both GPRC5A and RARβ in NSCLC cell line H157 by reverse transcription PCR (RT-PCR) analysis; however, the induction was eliminated when RARβ was knocked down by siRNA (Figure 5A).